TAMMY KELLY: Open Payments
NPI 1215267349 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 15 payments from 10 companies in 2025. Trend: 2023 $120 · 2024 $197 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $75 |
| Corcept Therapeutics | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Viatris Specialty LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: REXULTI, Korlym, BREZTRI, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), NURTEC ODT, YUPELRI, GVOKE HYPOPEN, JOURNAVX.
Industry payments across CA — which companies pay providers there.
